BioWorld Asia

Sep. 12, 2007

View Archived Issues

Swedish Study Finds Molecular Cause For Kidney Infections

Read More

Aptuit Paying $64M For Evotec Chemistry Unit

Read More

Antisoma's Lung Cancer Drug Repeats Strong Phase II Results

Read More

Biotech Fears Tough Restrictions From EU On Use of Primates

Read More

Nanobody Alliance With BI Could Net €200M For Ablynx

No Abstract Read More

FDA OKs TopoTarget's Totect For Extravasation Treatment

Read More

Other News To Note

Read More

BioAlliance Launches Loramyc; Pleased With Pricing Directive

Read More

Business and Academia Merge In UK-Australia Partnership

Read More

UK Opens Door to Work With Hybrid Embryos

LONDON - The UK regulator has agreed to the generation of human/animal hybrid embryos for stem cell research, paving the way for it to consider two applications for licenses to conduct such research. (BioWorld International) Read More

MediGene Gets $21M In Private Share Placement

Read More